Biogen Inc BIIB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:47 PM EDT
215.00quote price arrow down-0.63 (-0.29%)
Volume
401,473
Close
215.63quote price arrow down-0.71 (-0.33%)
Volume
1,509,969
52 week range
211.01 - 319.76
Loading...
  • Open217.36
  • Day High217.57
  • Day Low214.00
  • Prev Close216.34
  • 52 Week High319.76
  • 52 Week High Date06/12/23
  • 52 Week Low211.01
  • 52 Week Low Date03/26/24

Key Stats

  • Market Cap31.344B
  • Shares Out145.36M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta-0.01
  • YTD % Change-16.67

KEY STATS

  • Open217.36
  • Day High217.57
  • Day Low214.00
  • Prev Close216.34
  • 52 Week High319.76
  • 52 Week High Date06/12/23
  • 52 Week Low211.01
  • 52 Week Low Date03/26/24
  • Market Cap31.344B
  • Shares Out145.36M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta-0.01
  • YTD % Change-16.67

RATIOS/PROFITABILITY

  • EPS (TTM)7.98
  • P/E (TTM)27.03
  • Fwd P/E (NTM)13.99
  • EBITDA (TTM)2.545B
  • ROE (TTM)8.24%
  • Revenue (TTM)9.836B
  • Gross Margin (TTM)74.24%
  • Net Margin (TTM)11.81%
  • Debt To Equity (MRQ)46.88%

EVENTS

  • Earnings Date04/23/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include...
Caroline Dorsa
Independent Chairman of the Board
Christopher Viehbacher
President, Chief Executive Officer, Director
Michael McDonnell CPA
Chief Financial Officer, Executive Vice President
Nicole Murphy
Executive Vice President - Pharmaceutical Operations and Technology
Adam Keeney Ph.D.
Executive Vice President, Head of Corporate Development
Address
225 Binney Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
106.56-4.03-3.64%
ILMN
Illumina Inc
137.32-1.36-0.98%
BNTX
Biontech SE
92.25-0.72-0.77%
GRFS
Grifols SA
6.68+0.03+0.45%
CRL
Charles River Laboratories International Inc
270.95+1.58+0.59%